Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics.

Current cancer drug targets(2023)

引用 0|浏览8
暂无评分
摘要
The present study reveals that a combination of PAM and TMZ produces an effective anti-cancerous effect on breast cancer cells. Therefore, this novel therapeutic regimen is likely to provide a better treatment strategy for breast cancer.
更多
查看译文
关键词
MVA pathway,Pamidronate,breast cancer,pamidronate (PAM),proteomics,synergistic effect
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要